accountSkeptics argue that the open source philosophy conflicts with the requirements of drug development. secrets. Despite the skepticism, pharma continues to adopt the open source philosophy for select projects as reported in the July issue of Nature Biotechnology by Stephen Strauss. ("Pharma Embraces Open Source Models", Nature Biotechnology 28, 631-634, 2010).
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pharma Continues to Adopt Open Source Drug Discovery « Selican Technologies
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account